MTOR and hepatocellular carcinoma: Ultimately, by reframing the PI3K/Akt/mTOR pathway not as a simple linear cascade but as a centrally 'imprinted' immuno-metabolic coordinator, this review provides a unifying framework to reconceptualize the pathogenesis of MASH-driven HCC.